TerrAscend (OTCMKTS:TSNDF) Shares Up 6.1% - Should You Buy?

TerrAscend Corp. (OTCMKTS:TSNDF - Get Free Report)'s stock price shot up 6.1% during trading on Thursday . The stock traded as high as $0.36 and last traded at $0.35. 107,938 shares traded hands during trading, a decline of 75% from the average session volume of 436,655 shares. The stock had previously closed at $0.33.

Analysts Set New Price Targets

Separately, Atb Cap Markets upgraded TerrAscend from a "hold" rating to a "strong-buy" rating in a research report on Thursday, May 8th.

TerrAscend Price Performance

The company has a debt-to-equity ratio of 1.42, a current ratio of 1.31 and a quick ratio of 0.70. The stock's fifty day simple moving average is $0.32 and its 200-day simple moving average is $0.42. The company has a market capitalization of $117.70 million, a P/E ratio of -1.42 and a beta of 1.33.

TerrAscend (OTCMKTS:TSNDF - Get Free Report) last announced its quarterly earnings results on Thursday, May 8th. The company reported ($0.05) EPS for the quarter, missing analysts' consensus estimates of ($0.03) by ($0.02). The business had revenue of $71.00 million for the quarter, compared to the consensus estimate of $71.63 million. TerrAscend had a negative return on equity of 20.23% and a negative net margin of 25.27%. On average, equities analysts forecast that TerrAscend Corp. will post -0.14 earnings per share for the current fiscal year.

TerrAscend Company Profile

TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names.